{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T05:50:09Z","timestamp":1761630609419},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1038\/bjc.2012.5","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T17:32:06Z","timestamp":1329240726000},"page":"817-825","source":"Crossref","is-referenced-by-count":10,"title":["Long-term CIN3+ risk in women with abnormal cytology; role of hrHPV testing"],"prefix":"10.1038","volume":"106","author":[{"given":"M","family":"Kocken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Berkhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F J","family":"van Kemenade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J A","family":"Louwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Zaal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M A E","family":"Nobbenhuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Kenter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P J F","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C J L M","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T J M","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"key":"BFbjc20125_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/jnci\/djh037","volume":"96","author":"M Arbyn","year":"2004","unstructured":"Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dillner J (2004) Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96: 280\u2013293","journal-title":"J Natl Cancer Inst"},{"issue":"Suppl 3","key":"BFbjc20125_CR2","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.vaccine.2006.05.117","volume":"24","author":"M Arbyn","year":"2006","unstructured":"Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J (2006) Clinical applications of HPV testing: a summary of meta-analyses. Vaccine 24 (Suppl 3): 78\u201389","journal-title":"Vaccine"},{"key":"BFbjc20125_CR3","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1002\/ijc.20958","volume":"116","author":"AG Bais","year":"2005","unstructured":"Bais AG, Rebolj M, Snijders PJ, de Schipper FA, van der Meulen DA, Verheijen RH, Voorhorst F, van Ballegooijen M, Meijer CJ, Helmerhorst TJ (2005) Triage using HPV-testing in persistent borderline and mildly dyskaryotic smears: proposal for new guidelines. Int J Cancer 116: 122\u2013129","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR4","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ijc.22484","volume":"120","author":"AG Bais","year":"2007","unstructured":"Bais AG, van Kemenade FJ, Berkhof J, Verheijen RH, Snijders PJ, Voorhorst F, Babovic M, van Ballegooijen M, Helmerhorst TJ, Meijer CJ (2007) Human papillomavirus testing on self-sampled cervicovaginal brushes: an effective alternative to protect nonresponders in cervical screening programs. Int J Cancer 120: 1505\u20131510","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR5","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1158\/1055-9965.EPI-05-0764","volume":"15","author":"J Berkhof","year":"2006","unstructured":"Berkhof J, Bulkmans NW, Bleeker MC, Bulk S, Snijders PJ, Voorhorst FJ, Meijer CJ (2006) Human papillomavirus type-specific 18-month risk of high-grade cervical intraepithelial neoplasia in women with a normal or borderline\/mildly dyskaryotic smear. Cancer Epidemiol Biomarkers Prev 15: 1268\u20131273","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFbjc20125_CR6","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/ijc.20846","volume":"115","author":"J Berkhof","year":"2005","unstructured":"Berkhof J, de Bruijne MC, Zielinski GD, Bulkmans NW, Rozendaal L, Snijders PJ, Verheijen RH, Meijer CJ (2005) Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. Int J Cancer 115: 268\u2013275","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"FX Bosch","year":"2002","unstructured":"Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55: 244\u2013265","journal-title":"J Clin Pathol"},{"key":"BFbjc20125_CR8","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/ijc.22677","volume":"121","author":"S Bulk","year":"2007","unstructured":"Bulk S, Bulkmans NW, Berkhof J, Rozendaal L, Boeke AJ, Verheijen RH, Snijders PJ, Meijer CJ (2007) Risk of high-grade cervical intra-epithelial neoplasia based on cytology and high-risk HPV testing at baseline and at 6-months. Int J Cancer 121: 361\u2013367","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/jcp.2003.011841","volume":"57","author":"S Bulk","year":"2004","unstructured":"Bulk S, van Kemenade FJ, Rozendaal L, Meijer CJ (2004) The Dutch CISOE-A framework for cytology reporting increases efficacy of screening upon standardisation since 1996. J Clin Pathol 57: 388\u2013393","journal-title":"J Clin Pathol"},{"key":"BFbjc20125_CR10","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1016\/S0140-6736(07)61450-0","volume":"370","author":"N Bulkmans","year":"2007","unstructured":"Bulkmans N, Berkhof J, Rozendaal L, van Kemenade F, Boeke A, Bulk S, Voorhorst F, Verheijen R, van Groningen K, Boon M, Ruitinga W, van Ballegooijen M, Snijders P, Meijer C (2007) Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 370: 1740\u20131742","journal-title":"Lancet"},{"key":"BFbjc20125_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/ijc.20076","volume":"110","author":"NW Bulkmans","year":"2004","unstructured":"Bulkmans NW, Rozendaal L, Snijders PJ, Voorhorst FJ, Boeke AJ, Zandwijken GR, van Kemenade FJ, Verheijen RH, Groningen K, Boon ME, Keuning HJ, van Ballegooijen M, van den Brule AJ, Meijer CJ (2004) POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 110: 94\u2013101","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR12","doi-asserted-by":"publisher","first-page":"b2569","DOI":"10.1136\/bmj.b2569","volume":"339","author":"PE Castle","year":"2009","unstructured":"Castle PE, Rodriguez AC, Burk RD, Herrero R, Wacholder S, Alfaro M, Morales J, Guillen D, Sherman ME, Solomon D, Schiffman M (2009) Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study. BMJ 339: b2569","journal-title":"BMJ"},{"key":"BFbjc20125_CR13","doi-asserted-by":"publisher","first-page":"356e1","DOI":"10.1016\/j.ajog.2007.07.049","volume":"197","author":"PE Castle","year":"2007","unstructured":"Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M (2007) Risk assessment to guide the prevention of cervical cancer. Am J Obstet Gynecol 197: 356e1\u2013356e6","journal-title":"Am J Obstet Gynecol"},{"key":"BFbjc20125_CR14","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1471-0528.2010.02519.x","volume":"117","author":"S Cotton","year":"2010","unstructured":"Cotton S, Sharp L, Little J, Cruickshank M, Seth R, Smart L, Duncan I, Harrild K, Neal K, Waugh N, Trial Of Management of B & Other Low-grade Abnormal Smears G (2010) The role of human papillomavirus testing in the management of women with low-grade abnormalities: multicentre randomised controlled trial. BJOG 117: 645\u2013659","journal-title":"BJOG"},{"key":"BFbjc20125_CR15","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1016\/S0140-6736(03)14955-0","volume":"362","author":"J Cuzick","year":"2003","unstructured":"Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, McGoogan E, Menon U, Terry G, Edwards R, Brooks C, Desai M, Gie C, Ho L, Jacobs I, Pickles C, Sasieni P (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362: 1871\u20131876","journal-title":"Lancet"},{"key":"BFbjc20125_CR16","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/ijc.23339","volume":"122","author":"J Cuzick","year":"2008","unstructured":"Cuzick J, Szarewski A, Mesher D, Cadman L, Austin J, Perryman K, Ho L, Terry G, Sasieni P, Soutter WP (2008) Long-term follow-up of cervical abnormalities among women screened by HPV testing and cytology-results from the Hammersmith study. Int J Cancer 122: 2294\u20132300","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR17","doi-asserted-by":"publisher","first-page":"a1754","DOI":"10.1136\/bmj.a1754","volume":"337","author":"J Dillner","year":"2008","unstructured":"Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, Cuzick J, van Ballegooijen M, Clavel C, Iftner T, Joint European Cohort S (2008) Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. Bmj 337: a1754","journal-title":"Bmj"},{"key":"BFbjc20125_CR18","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1023\/A:1018435522475","volume":"8","author":"L Gustafsson","year":"1997","unstructured":"Gustafsson L, Ponten J, Zack M, Adami HO (1997) International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8: 755\u2013763","journal-title":"Cancer Causes Control"},{"key":"BFbjc20125_CR19","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","volume":"12","author":"HA Katki","year":"2011","unstructured":"Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE (2011) Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 12: 663\u2013672","journal-title":"Lancet Oncol"},{"key":"BFbjc20125_CR20","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/bjc.2011.326","volume":"105","author":"RS Kelly","year":"2011","unstructured":"Kelly RS, Patnick J, Kitchener HC, Moss SM (2011) HPV testing as a triage for borderline or mild dyskaryosis on cervical cytology: results from the Sentinel Sites study. Br J Cancer 105: 983\u2013988","journal-title":"Br J Cancer"},{"key":"BFbjc20125_CR21","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1093\/jnci\/dji187","volume":"97","author":"MJ Khan","year":"2005","unstructured":"Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97: 1072\u20131079","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc20125_CR22","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.ejca.2011.01.008","volume":"47","author":"HC Kitchener","year":"2011","unstructured":"Kitchener HC, Gilham C, Sargent A, Bailey A, Albrow R, Roberts C, Desai M, Mather J, Turner A, Moss S, Peto J (2011) A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: extended follow up in the ARTISTIC trial. Eur J Cancer 47: 864\u2013871","journal-title":"Eur J Cancer"},{"key":"BFbjc20125_CR23","doi-asserted-by":"publisher","first-page":"10630","DOI":"10.1158\/0008-5472.CAN-06-1057","volume":"66","author":"S Kjaer","year":"2006","unstructured":"Kjaer S, Hogdall E, Frederiksen K, Munk C, van den BA, Svare E, Meijer C, Lorincz A, Iftner T (2006) The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period. Cancer Res 66: 10630\u201310636","journal-title":"Cancer Res"},{"key":"BFbjc20125_CR24","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/cncy.20172","volume":"119","author":"AW Levi","year":"2011","unstructured":"Levi AW, Harigopal M, Hui P, Schofield K, Chhieng DC (2011) Use of high-risk human papillomavirus testing in patients with low-grade squamous intraepithelial lesions. Cancer Cytopathol 119: 228\u2013234","journal-title":"Cancer Cytopathol"},{"key":"BFbjc20125_CR25","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1001\/jama.281.17.1605","volume":"281","author":"MM Manos","year":"1999","unstructured":"Manos MM, Kinney WK, Hurley LB, Sherman ME, Shieh-Ngai J, Kurman RJ, Ransley JE, Fetterman BJ, Hartinger JS, McIntosh KM, Pawlick GF, Hiatt RA (1999) Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 281: 1605\u20131610","journal-title":"JAMA"},{"key":"BFbjc20125_CR26","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1056\/NEJMoa071430","volume":"357","author":"MH Mayrand","year":"2007","unstructured":"Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlee F, Franco EL (2007) Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357: 1579\u20131588","journal-title":"N Engl J Med"},{"key":"BFbjc20125_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S1470-2045(08)70103-7","volume":"9","author":"MR McCredie","year":"2008","unstructured":"McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 9: 425\u2013434","journal-title":"Lancet Oncol"},{"key":"BFbjc20125_CR28","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1056\/NEJMoa073204","volume":"357","author":"P Naucler","year":"2007","unstructured":"Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, Radberg T, Strander B, Johansson B, Forslund O, Hansson BG, Rylander E, Dillner J (2007) Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 357: 1589\u20131597","journal-title":"N Engl J Med"},{"key":"BFbjc20125_CR29","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0140-6736(01)06809-X","volume":"358","author":"MA Nobbenhuis","year":"2001","unstructured":"Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Bezemer PD, Verheijen RH, Meijer CJ (2001) Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 358: 1782\u20131783","journal-title":"Lancet"},{"key":"BFbjc20125_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/S0140-6736(98)12490-X","volume":"354","author":"MA Nobbenhuis","year":"1999","unstructured":"Nobbenhuis MA, Walboomers JM, Helmerhorst TJ, Rozendaal L, Remmink AJ, Risse EK, van der Linden HC, Voorhorst FJ, Kenemans P, Meijer CJ (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20\u201325","journal-title":"Lancet"},{"key":"BFbjc20125_CR31","unstructured":"NVOG (2004) National Guideline \u2018Cervical Intraepithelial Neoplasia\u2019, (in Dutch), http:\/\/www.oncoline.nl\/cervicale-intra-epitheliale-neoplasie (accessed on 7 September 2011)"},{"key":"BFbjc20125_CR32","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.ygyno.2007.01.023","volume":"105","author":"P Petignat","year":"2007","unstructured":"Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F (2007) Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecol Oncol 105: 530\u2013535","journal-title":"Gynecol Oncol"},{"key":"BFbjc20125_CR33","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/ijc.25485","volume":"128","author":"NG Powell","year":"2011","unstructured":"Powell NG, Hibbitts SJ, Boyde AM, Newcombe RG, Tristram AJ, Fiander AN (2011) The risk of cervical cancer associated with specific types of human papillomavirus: a case-control study in a UK population. Int J Cancer 128: 1676\u20131682","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR34","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/ijc.24891","volume":"126","author":"DC Rijkaart","year":"2009","unstructured":"Rijkaart DC, Berkhof J, van Kemenade FJ, Rozendaal L, Verheijen RH, Bulk S, Herreilers ME, Verweij WM, Snijders PJ, Meijer CJ (2009) Comparison of HPV and cytology triage algorithms for women with borderline or mild dyskaryosis in population-based cervical screening (VUSA-screen study). Int J Cancer 126: 2175\u20132181","journal-title":"Int J Cancer"},{"key":"BFbjc20125_CR35","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1158\/0008-5472.CAN-08-4192","volume":"69","author":"M Safaeian","year":"2009","unstructured":"Safaeian M, Schiffman M, Gage J, Solomon D, Wheeler CM, Castle PE (2009) Detection of precancerous cervical lesions is differential by human papillomavirus type. Cancer Res 69: 3262\u20133266","journal-title":"Cancer Res"},{"key":"BFbjc20125_CR36","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1097\/01.AOG.0000263461.71732.40","volume":"109","author":"M Safaeian","year":"2007","unstructured":"Safaeian M, Solomon D, Wacholder S, Schiffman M, Castle P (2007) Risk of precancer and follow-up management strategies for women with human papillomavirus-negative atypical squamous cells of undetermined significance. Obstet Gynecol 109: 1325\u20131331","journal-title":"Obstet Gynecol"},{"key":"BFbjc20125_CR37","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1158\/1055-9965.EPI-11-0206","volume":"20","author":"M Schiffman","year":"2011","unstructured":"Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, Buckland J, Sherman ME, Rydzak G, Kirk P, Lorincz AT, Wacholder S, Burk RD (2011) A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev 20: 1398\u20131409","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFbjc20125_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.virol.2005.04.002","volume":"337","author":"M Schiffman","year":"2005","unstructured":"Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, Bratti MC, Sherman ME, Morales J, Guillen D, Alfaro M, Hutchinson M, Wright TC, Solomon D, Chen Z, Schussler J, Castle PE, Burk RD (2005) The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 337: 76\u201384","journal-title":"Virology"},{"key":"BFbjc20125_CR39","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1093\/jnci\/95.1.46","volume":"95","author":"ME Sherman","year":"2003","unstructured":"Sherman ME, Lorincz AT, Scott DR, Wacholder S, Castle PE, Glass AG, Mielzynska-Lohnas I, Rush BB, Schiffman M (2003) Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 95: 46\u201352","journal-title":"J Natl Cancer Inst"},{"key":"BFbjc20125_CR40","first-page":"101","volume":"119","author":"PJ Snijders","year":"2005","unstructured":"Snijders PJ, van den Brule AJ, Jacobs MV, Pol RP, Meijer CJ (2005) HPV DNA detection and typing in cervical scrapes. Methods Mol Med 119: 101\u2013114","journal-title":"Methods Mol Med"},{"key":"BFbjc20125_CR41","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1016\/S0959-8049(00)00317-8","volume":"36","author":"M van Ballegooijen","year":"2000","unstructured":"van Ballegooijen M, Hermens R (2000) Cervical cancer screening in the Netherlands. Eur J Cancer 36: 2244\u20132246","journal-title":"Eur J Cancer"},{"key":"BFbjc20125_CR42","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1128\/JCM.40.3.779-787.2002","volume":"40","author":"AJ van den Brule","year":"2002","unstructured":"van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ (2002) GP5+\/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 40: 779\u2013787","journal-title":"J Clin Microbiol"},{"key":"BFbjc20125_CR43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"JM Walboomers","year":"1999","unstructured":"Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 12\u201319","journal-title":"J Pathol"},{"key":"BFbjc20125_CR44","first-page":"248","volume-title":"Blaustein's Pathology of the Female Genital Tract","author":"TC Wright","year":"1995","unstructured":"Wright TC (1995) Precancerous lesions of the cervix. In Blaustein's Pathology of the Female Genital Tract, Kumar RJ (ed) pp, 248\u201357. Springer Verlag: New York"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/bjc20125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20125","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/bjc20125.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T18:26:40Z","timestamp":1713551200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bjc20125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["BFbjc20125"],"URL":"https:\/\/doi.org\/10.1038\/bjc.2012.5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}